{"id":"W2343867010","doi":"10.1200/jco.2015.33.15_suppl.8503","title":"Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed/refractory (RR) follicular lymphoma (FL): Durable responses at lower dose level.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Toxicity; Gastroenterology; Follicular lymphoma; Surgery; Animal science; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000487989,0.0003818869,0.0006574732,0.000369239,0.0001792633,0.0005160774,0.0004053759,0.0005865311,0.002449102],"category_scores_gemma":[0.0006893027,0.0002783928,0.0004311405,0.0002632551,0.000312502,0.0005113144,0.000254675,0.001094443,0.0003874021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006488802,"about_ca_system_score_gemma":0.0003628489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004172827,"about_ca_topic_score_gemma":0.001002525,"domain_scores_codex":[0.9997314,0.0001273184,0.00001789515,0.00004241436,0.00002563326,0.00005534937],"domain_scores_gemma":[0.9997966,0.00005078119,0.00004203168,0.00002182112,0.000007467771,0.00008130993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5151019,0.02751337,0.03641717,0.0006028336,0.0008826509,0.0008449618,0.0006652002,0.004973959,0.06747796,0.0004441217,0.0020724,0.3430034],"study_design_scores_gemma":[0.1161243,0.7724795,0.08761364,0.00007651313,0.0005434068,0.00102336,0.000183786,0.003028395,0.01264815,0.0003920643,0.005845375,0.00004150864],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979532,0.0008860669,0.0001539973,0.00007764887,0.00002228472,0.0001409788,0.00009698854,0.00002530406,0.000643454],"genre_scores_gemma":[0.9987797,0.0002506271,0.0001846868,0.00007103573,0.00002579542,0.00008783738,0.000157927,0.000002794569,0.0004394246],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002449102,"threshold_uncertainty_score":0.008193016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08271772342329124,"score_gpt":0.4069899008915511,"score_spread":0.3242721774682598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}